Mechanism of Action: Aryl Hydrocarbon Receptor Agonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Aryl Hydrocarbon Receptor Agonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Llc | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 10,647,649 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Organon Llc | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 11,617,724 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Organon Llc | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 11,597,692 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Organon Llc | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 11,590,088 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Organon Llc | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 10,195,160 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
